DK149589D0 - Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme - Google Patents

Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme

Info

Publication number
DK149589D0
DK149589D0 DK149589A DK149589A DK149589D0 DK 149589 D0 DK149589 D0 DK 149589D0 DK 149589 A DK149589 A DK 149589A DK 149589 A DK149589 A DK 149589A DK 149589 D0 DK149589 D0 DK 149589D0
Authority
DK
Denmark
Prior art keywords
hiv
muterated
producing same
dna
dna sequence
Prior art date
Application number
DK149589A
Other languages
English (en)
Other versions
DK149589A (da
Inventor
Joseph Mccrary Mccune
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of DK149589D0 publication Critical patent/DK149589D0/da
Publication of DK149589A publication Critical patent/DK149589A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK149589A 1988-03-28 1989-03-28 Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme DK149589A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17400588A 1988-03-28 1988-03-28

Publications (2)

Publication Number Publication Date
DK149589D0 true DK149589D0 (da) 1989-03-28
DK149589A DK149589A (da) 1989-09-29

Family

ID=22634418

Family Applications (1)

Application Number Title Priority Date Filing Date
DK149589A DK149589A (da) 1988-03-28 1989-03-28 Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme

Country Status (5)

Country Link
EP (1) EP0335635A1 (da)
JP (1) JPH029372A (da)
AU (1) AU3170089A (da)
DK (1) DK149589A (da)
IL (1) IL89567A0 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02203783A (ja) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd 抗原性を有する非感染性エイズウイルス産生クローン化ヒトｔ細胞
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
WO1991015238A1 (en) * 1990-04-03 1991-10-17 Genentech, Inc. Methods and compositions for vaccination against hiv
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
WO1991019795A1 (en) * 1990-06-19 1991-12-26 Immuvax Nonpathogenic variant virus
GB9106048D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccines
AU654970B2 (en) * 1990-09-28 1994-12-01 Smithkline Beecham Biologicals (Sa) Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
JP2767078B2 (ja) * 1990-10-17 1998-06-18 アメリカ合衆国 Ｈｉｖ―１の分子クローンとその使用法
FR2676071B1 (fr) * 1991-05-02 1994-11-18 Transgene Sa Nouveau variant gp160 non-clivable, soluble, de forme hybride.
US6174666B1 (en) 1992-03-27 2001-01-16 The United States Of America As Represented By The Department Of Health And Human Services Method of eliminating inhibitory/instability regions from mRNA
AU673514B2 (en) * 1992-03-27 1996-11-14 International Flower Developments Pty Ltd Genetic sequences encoding flavonoid pathway enzymes and uses therefor
GB9215233D0 (en) * 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
WO1994016081A1 (de) * 1993-01-16 1994-07-21 Manfred Schawaller Verfahren zur gewinnung nativer domänen viraler membranproteine, deren verwendung, insbesondere als impfstoff gegen hiv
AU700371B2 (en) * 1993-06-07 1999-01-07 Genentech Inc. Hiv envelope polypeptides
US5795737A (en) * 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
US6114148C1 (en) * 1996-09-20 2012-05-01 Gen Hospital Corp High level expression of proteins
CA2401974C (en) * 2000-03-02 2013-07-02 Emory University Dna expression vectors and methods of use
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
EP1311686A2 (en) * 2000-08-14 2003-05-21 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
JP4554887B2 (ja) 2001-03-08 2010-09-29 アメリカ合衆国 改変ＨＩＶエンベロープ、ｇａｇ、およびｐｏｌ遺伝子を発現するＭＶＡ
WO2003059385A2 (en) * 2002-01-14 2003-07-24 Chiron Corporation Hiv vaccine and method of use
EA032929B1 (ru) 2011-05-17 2019-08-30 Дзе Рокфеллер Юниверсити Нейтрализующее вирус иммунодефицита человека антитело и способы его применения
EP2893347A4 (en) * 2012-09-04 2016-03-23 Mbio Diagnostics Inc SYSTEM AND METHOD FOR ENHANCING THE ASSAY OF BIOMARKERS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2606029B2 (fr) * 1986-04-08 1989-02-03 Transgene Sa Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
EP0272858A3 (en) * 1986-12-15 1989-07-12 Repligen Corporation Recombinant hiv envelope proteins produced in insect cells

Also Published As

Publication number Publication date
DK149589A (da) 1989-09-29
AU3170089A (en) 1989-09-28
JPH029372A (ja) 1990-01-12
IL89567A0 (en) 1989-09-10
EP0335635A1 (en) 1989-10-04

Similar Documents

Publication Publication Date Title
DK149589D0 (da) Dna-sekvens, dna-vektor, muteret hiv-virusgenom, hiv-vaccine og fremgangsmaade til fremstilling af samme
DK166087A (da) Htlv-iii-virusprotein, dna-sekvens, der koder herfor, fremgangsmaade til fremstilling heraf, fremgangsmaade til detektion af aids-virus samt antistoffer mod aids-virus
NO871025L (no) Polypeptid, dna og fremgangsmaate for fremstilling derav.
DK210283A (da) Fremgangsmaade til fremstilling af plasma, plasmapraeparat og vaccine mod hepatitis
KR870007282A (ko) 효모에서 b형 간염 바이러스 단백질을 제조하는 방법
DK57391A (da) Hiv proteiner og peptider til anvendelse ved diagnosticering, profylakse og behandling af aids
NO912825L (no) Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper.
DK61792A (da) Fremgangsmaade til fremstilling af 2-chlor-4,6-diamino-5-cyano-pyrimidin
DK323086D0 (da) Vacciner og diagnostica afledt af kvaegdiarre-virus
NL189207C (nl) Flavivirus antigeen, werkwijze ter bereiding daarvan, tussenprodukten en werkwijze ter bereiding van een vaccin tegen japanse encefalitis.
DK438288D0 (da) Hybrid picornavirus samt fremgangsmaade til fremstilling deraf og vaccine paa basis af en saadan virus
DK157089D0 (da) Ziegler-natta-katalysator, fremgangsmaade til fremstilling heraf og anvendelse af samme
DK401787D0 (da) Spraenghoved og metode til fremstilling af samme
DK44788D0 (da) Svaekket cytomegalovirus, vaccine indeholdende et saadant virus og dna-konstruktion
DK282384D0 (da) Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
DK601687D0 (da) Rensede adenyl-cyclase-praeparater, fremgangsmaade til opnaaelse af saadanne praeparater og deres biologiske anvendelser
DK482583A (da) Dna-sekvens, dna-strukturer og fremgangsmaade til fremstilling af penicillin-acylase under anvendelse deraf
DK592284D0 (da) Toxoid, vaccinepraeparat indeholdende det og fremgangsmaade til fremstilling af det
DK694487D0 (da) 1-acyl-2,3-dihydro-4(1h)-quinolinon-4-oximderivater og fremgangsmaade til fremstilling af samme
DK417787A (da) Fremgangsmaade til fremstilling af 7-oxo-4-thia-1-azabicyclo-(3,2,0)hept-2-en-derivater
DK448687D0 (da) Dna, der koder for et virusantigen
DK199801023A (da) Nukleotid sekvens, ekspressionsplasmid og fremgangsmåde til oprensning af aFGF
FI952778A0 (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
NO894821D0 (no) Homopolysakkarid, opploesning derav, og deres fremstillingog anvendelse.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment